Accessibility settings

Published on in Vol 5 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/89750, first published .
Hand pressing the search button on a digital interface

Current Landscape of Generative AI Use as a Search Engine Among Resident Physicians: Cross-Sectional Study

Current Landscape of Generative AI Use as a Search Engine Among Resident Physicians: Cross-Sectional Study

1Department of Infectious Diseases, University of Tokyo Hospital, Tokyo, Japan

2Department of Infectious Diseases, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, 1-5-45 Yushima, Bunkyo-ku, Tokyo, Japan

3Division of Medical Education, Faculty of Medicine, Juntendo University, Tokyo, Japan

4Muribushi Okinawa Center for Teaching Hospitals, Urasoe, Okinawa, Japan

Corresponding Author:

Koh Okamoto, MD, MS, PhD


Background: Acquiring generative AI (GenAI) literacy and avoiding knowledge collapse and inadequate skill development are critical for resident physicians in the GenAI era, who are highly susceptible to its influence, including those who are current nonusers.

Objective: This study examined the degree of GenAI use as a search engine in clinical practice among resident physicians and compared differences in AI literacy and bedside behaviors in the management of infectious diseases between GenAI users and nonusers.

Methods: This cross-sectional study was conducted through an original questionnaire survey administered in January 2025 to participants of the General Medicine In-Training Examination (GM-ITE), a nationwide computer-based test for postgraduate year 1 and year 2 resident physicians in Japan. The survey items covered the degree of GenAI use, GenAI literacy, and perceived bedside behaviors. In addition to the GM-ITE score, we collected data on demographics and survey responses. Statistical analysis was performed to compare attitudes toward GenAI use between GenAI users and nonusers. Additionally, the difference in their bedside behaviors in infectious disease management was assessed, adjusted for demographics, the learning environment, and GM-ITE score.

Results: Of 9179 GM-ITE examinees, 2989 (32.6%) resident physicians from 546 hospitals completed the survey. Subsequent analyses were performed in 2850 respondents who answered the question regarding GenAI use as a search engine in clinical work. A total of 1124 (39.4%) participants reported using GenAI as a search engine, while 1726 (60.6%) were nonusers. Only 13% (144/1110) of users relied on it as a primary reference for differential diagnoses. Compared with nonusers, users were more likely to understand limitations such as confabulation (817/1103, 74.1% vs 991/1696, 58.4%; P<.001) and to recognize competencies essential for future physicians in infectious disease management, including history taking and physical examination (965/1106, 87.3% vs 1296/1706, 76%; P<.001). Ethical considerations were less commonly addressed overall, with 47.3% (1311/2770) examining fairness and 49.8% (1381/2774) examining transparency. Awareness was greater among users than nonusers (615/1092, 56.3% vs 696/1678, 41.5%; P<.001 for fairness and 645/1095, 58.9% vs 736/1679, 43.8%; P<.001 for transparency). GenAI use was independently associated with perceived favorable behaviors, such as thorough examination (adjusted odds ratio [aOR] 1.42, 95% CI 1.18‐1.70) and appropriate antimicrobial use (aOR 1.57, 95% CI 1.32‐1.87).

Conclusions: Although GenAI use was not associated with self-reported behaviors indicative of knowledge collapse at this stage, GenAI literacy among resident physicians in Japan remains limited, particularly among nonusers. Given its rapid expansion, education on GenAI in clinical practice may be necessary for both users and nonusers, emphasizing critical thinking and ethical considerations, including transparency, in patient care.

JMIR AI 2026;5:e89750

doi:10.2196/89750

Keywords



In recent years, generative AI (GenAI) has gained significant attention and has been increasingly integrated into clinical care. GenAI is expected to serve as an “interactive encyclopedia,” supporting clinical decisions by providing disease information, listing differential diagnoses, and suggesting treatment options at a level comparable to those of physicians [1-4]. However, its inherent limitations, stemming from its stochastic nature and training data, include confabulations and biases [5]. These limitations are compounded by human cognitive bias toward GenAI outputs [2,6].

Concerns around knowledge collapse and inadequate skill development (eg, deskilling, never-skilling, and mis-skilling) among physicians who overrely on GenAI are also emerging [2,7,8]. They are theoretically caused by cognitive off-loading and have already been documented in endoscopists [9]. We hypothesized that a similar phenomenon may be observed in other competencies, including those that remain indispensable even when using GenAI. For example, clinical reasoning grounded in pathophysiological knowledge is essential for identifying confabulations [8,10]. Similarly, considering local disease epidemiology is crucial to counter biases embedded in large databases [6]. Moreover, thorough history taking and physical examination skills are unlikely to be replaced by GenAI [11,12]. The importance of these competencies is particularly true for infectious diseases (IDs), where bedside evaluation and awareness of local pathogen epidemiology and antimicrobial resistance are central to diagnosis and treatment but are insufficiently represented in current GenAI models [6].

Resident physicians’ recognition of these drawbacks is of paramount importance. First, as digital natives, they may be less critical of advanced technologies [13]. Second, with limited clinical experience, they may struggle to evaluate the accuracy of GenAI outputs [13]. Third, their clinical performance has enduring implications for patient care. These concerns extend to GenAI nonusers, given that the adoption of GenAI in medicine is unlikely to cease [2]. However, the preparedness of nonusers for its future integration remains unclear.

This study aimed to explore the current landscape of (1) the resident physicians’ use of GenAI in clinical practice, (2) awareness of GenAI’s limitations among users and nonusers, and (3) differences in bedside behaviors regarding the management of IDs between the two groups to assess knowledge collapse and inadequate skill development among GenAI users.


Study Setting, Study Participants, and Data Source

We conducted a cross-sectional study in January 2025 among examinees of the General Medicine In-Training Examination (GM-ITE) in Japan, where the academic year runs from April to March. The GM-ITE is a nationwide, annual computer-based test consisting of 80 multiple-choice clinical questions for postgraduate year (PGY) 1 and PGY 2 resident physicians. It has been administered by the Japan Institute for Advancement of Medical Education Program (JAMEP), a nonprofit organization that evaluates medical education in Japan, since 2011. In 2024, 9580 resident physicians—approximately half of all PGY 1 and PGY 2 residents in Japan—took the examination [14]. GM-ITE data have been widely used in medical education research [15-19].

We developed a 29-item multiple-choice electronic survey addressing GenAI use in daily life outside clinical work, GenAI use as a search engine, and bedside behaviors in ID management (Multimedia Appendix 1), which was disseminated concurrently with the examination. The variable regarding GenAI use in daily life was collected to provide contextual information on study participants. Participation was voluntary, and respondents received an online reference list of common pathogens and antimicrobials, which did not contain GenAI-related content, as an incentive. All GM-ITE examinees who responded to our survey and consented to the use of their responses for research purposes were included in our study. For the comparison between resident physicians with and without GenAI use as a search engine, we analyzed responses only from individuals who responded to the relevant item.

In Japan, 2-year residency programs start in April and end in March. They are mandatory for all medical school graduates seeking clinical positions, regardless of their desired specialty. An ID department rotation is elective, whereas an antimicrobial stewardship program is not included [15].

Questionnaire Development

GenAI use as a search engine in daily life and in clinical work was assessed using separate survey items. We designed the survey to evaluate respondents’ GenAI literacy using Bloom’s taxonomy of learning domains, a framework commonly applied in medical education [20]. The framework comprises the psychomotor (eg, practical skills), cognitive (eg, knowledge), and affective (eg, attitudes or medical ethics) domains. In the psychomotor domain, we investigated whether a respondent used GenAI to gain information about the disease of interest or to help enumerate differential diagnoses. The cognitive domain examined perceived GenAI literacy, including confabulation [6,21], biased output [6], automation bias [2,6], physicians’ knowledge collapse and deskilling [2,8], and uninformed use of GenAI in patient care [22], as a surrogate for true GenAI literacy. It also addressed competencies considered essential regardless of GenAI, such as history taking, physical examination [11,12], pathophysiological knowledge, and clinical reasoning [8,10]. The affective domain adopted the FAVES (fairness, appropriateness, validity, effectiveness, and safety) framework and transparency, an expansion of the Belmont principles (ie, beneficence, respect for people, and justice), to assess ethical considerations of GenAI [22].

Furthermore, we also included items on bedside behaviors crucial to ID management and likely to remain essential, including history taking, physical examination, clinical reasoning, recognition of local epidemiology (ie, epidemics and antibiogram data), and individualization of care goals [6,8,10-12]. We piloted the survey among resident physicians at the University of Tokyo Hospital to evaluate clarity and feasibility. After administration of the GM-ITE, demographic information and survey responses were collected.

Statistical Analysis

In statistical hypothesis testing, responses on a 5-point Likert scale were dichotomized: scores 1 to 3 (strongly disagree, disagree, and neutral) were categorized as “not applicable” and scores 4 to 5 (agree and strongly agree) as “applicable” and then summarized as proportions, including the items assessing GenAI use as a search engine and bedside behaviors. Associations between GenAI use and respondents’ demographics and cognitive and affective domains were assessed using univariable chi-square tests.

Our previous study suggested the potential independent effect of an ID department rotation and the presence of antimicrobial stewardship programs on the performance of resident physicians in managing IDs [15]. Therefore, this study used multivariable logistic regression to examine associations between GenAI use (independent variable) and bedside behaviors (dependent variables), adjusting for these two factors, alongside sex, PGY, institution type (ie, university or community hospital), and overall GM-ITE score.

We performed a sensitivity analysis on the cutoff of item responses, wherein 5-point Likert scale items were dichotomized into scores 1 to 2 and scores 3 to 5. This shift also applied to the cutoff used to distinguish between GenAI users and nonusers. Statistical significance was defined as a 2-tailed P<.05. Throughout the statistical testing, complete-case analyses were conducted because the proportion of missing values remained below 5% [23]. Analyses were conducted using Stata (version 16; StataCorp LLC).

Ethical Considerations

This study was approved by the Institutional Review Board of JAMEP (number 24‐20). All survey responses were examined after obtaining informed consent from the study participants. The study data were deidentified, and no identification of individual participants is possible in any portion of the manuscript or supplementary material. The study adhered to the STROBE (Strengthening the Reporting of Observational Studies in Epidemiology) reporting guidelines.


Characteristics of Study Participants

Of 9179 GM-ITE participants, 2989 (32.6%) resident physicians from 546 hospitals completed the survey, including 1002 (33.5%) female respondents. Respondents comprised 1506 (50.4%) PGY 1 and 1483 (49.6%) PGY 2, with 2701 (90.4%) aged <30 years. Most respondents (n=2401, 80.3%) worked in community hospitals. Overall, 1948 (68.4%) reported using GenAI in daily life outside clinical work.

After excluding 139 (4.3%) resident physicians who did not respond to the item regarding GenAI use as a search engine, the remaining 2850 respondents were included in subsequent analyses. Differences between GenAI users (n=1124, 39.4%) and nonusers (n=1726, 60.6%) are summarized in Table 1. On the basis of the proportion of GenAI users among each sex, female respondents were less likely than male respondents to use GenAI as a search engine (350/963, 36.3% vs 774/1887, 41%; P=.02). GenAI users relied on self-study more frequently than nonusers (759/1118, 67.9% vs. 981/1706, 57.5%; P<.001). No statistically significant differences were observed in the proportion of PGY 1 residents (P=.72), individuals aged <30 years (P=.40), or individuals working at a university hospital (P=.84).

Table 1. Association between the use of generative AI (GenAI) as a search engine and resident physicians’ demographics and educational resources (N=2850a).
VariablesOverall (n=2850), n (%)GenAI users (n=1124), n (%)GenAI nonusers (n=1726), n (%)P value
Participants demographics
Sex.02
  Male1887 (66.2)774 (68.9)1113 (64.5)
  Female963 (33.8)350 (31.1)613 (35.5)
PGYb.72
  PGY 11424 (50)557 (49.6)867 (50.2)
  PGY 21426 (50)567 (50.4)859 (49.8)
Age <30 y (n=2714)c2435 (89.7)971 (90.3)1464 (89.3).40
Institution type.84
  University hospital548 (19.2)214 (19)334 (19.4)
  Community hospital2302 (80.8)910 (81)1392 (80.6)
Educational resources
I have received training on the application of GenAI as a search engine (n=2837)d.339 (12)210 (18.8)129 (7.5)<.001
I rely on self-study instead of seeking advice from an attending physician to address questions (n=2824)e.1740 (61.6)759 (67.9)981 (57.5)<.001
What resources do you primarily use to address questions concerning unfamiliar diseases? (n=2827)f
 Printed or electronic textbooks1150 (40.7)419 (37.7)731 (42.6)g
 Medical apps762 (27)310 (27.9)452 (26.4)
 Internet search without using GenAI636 (22.5)216 (19.4)420 (24.5)
 GenAI-generated articles or summaries168 (5.9)117 (10.5)51 (3)
 Review articles74 (2.6)32 (2.9)42 (2.4)
 Original articles37 (1.3)18 (1.6)19 (1.1)
What resources do you primarily use to address questions concerning familiar diseases? (n=2819)h
 Printed or electronic textbooks1567 (55.6)592 (53.3)975 (57.1)
 Medical apps652 (23.1)255 (23)397 (23.2)
 Internet search without using GenAI399 (14.2)134 (12.1)265 (15.5)
 GenAI-generated articles or summaries134 (4.8)97 (8.7)37 (2.2)
 Review articles49 (1.7)23 (2.1)26 (1.5)
 Original articles18 (0.6)10 (0.9)8 (0.5)
What resources do you primarily use to address differential diagnoses? (n=2817)i
 Printed or electronic textbooks1611 (57.2)600 (54.1)1011 (59.2)
 Medical apps579 (20.6)210 (18.9)369 (21.6)
 Internet search without using GenAI393 (14)129 (11.6)264 (15.5)
 GenAI-generated articles or summaries188 (6.7)144 (13.0)44 (2.6)
 Review articles32 (1.1)20 (1.8)12 (0.7)
 Original articles14 (0.5)7 (0.6)7 (0.4)

aResponses from some study participants are missing.

bPGY: postgraduate year.

cOverall: n= 2714; GenAI users: n=1075; GenAI nonusers: n=1639.

dOverall: n= 2837; GenAI users: n=1120; GenAI nonusers: n=1717.

eOverall: n= 2824; GenAI users: n=1118; GenAI nonusers: n=1706.

fOverall: n= 2827; GenAI users: n=1112; GenAI nonusers: n=1715.

gStatistical testing is not applicable.

hOverall: n= 2819; GenAI users: n=1111; GenAI nonusers: n=1708.

iOverall: n= 2817; GenAI users: n=1110; GenAI nonusers: n=1707.

Psychomotor Domain of GenAI Use Among Resident Physicians

Among all respondents (n=2850), 344 (12.1%) reported receiving training in GenAI use as a search engine. GenAI was infrequently used as the primary educational resource: 13% (144/1110) of respondents used it for differential diagnoses, 10.5% (117/1112) for unfamiliar diseases, and 8.7% (97/1111) for familiar diseases. Even among GenAI users, printed or electronic textbooks remained the predominant educational resource: 54.1% (600/1110) for differential diagnoses, 53.3% (592/1111) for familiar diseases, and 37.7% (419/1112) for unfamiliar diseases.

Cognitive Domain of GenAI Use Among Resident Physicians

The distribution of responses for each item on 5-category scales was illustrated in Multimedia Appendix 2. GenAI’s potential for confabulation and bias was recognized by 64.6% (1808/2799) and 60.2% (1679/2790) of respondents, respectively, while only 48.8% (1356/2777) acknowledged patients’ right to be informed of GenAI use. Awareness was consistently higher among GenAI users than nonusers (Table 2 and Figure 1): confabulation (817/1103, 74.1% vs 991/1696, 58.4%; P<.001), biased output (769/1101, 69.8% vs 910/1689, 53.9%; P<.001), automation bias (743/1099, 67.6% vs 885/1690, 52.4%; P<.001), knowledge collapse (664/1099, 60.4% vs 905/1683, 53.8%; P=.001), and informing patients of GenAI use (578/1102, 52.5% vs 778/1675, 46.4%; P=.002).

Figure 1. Resident physicians’ perceived generative AI (GenAI) literacy in cognitive and affective domains.
Table 2. Association between the use of generative AI (GenAI) as a search engine and resident physicians’ perceived GenAI literacy in cognitive and affective domains (n=2850a).
VariablesOverall, n (%)GenAI users, n (%)GenAI nonusers, n (%)P value
Cognitive domain
I know that GenAI has the potential to confabulate (n=2799)b1808 (64.6)817 (74.1)991 (58.4)<.001
I know that GenAI outputs may be biased, reflecting the learning data (n=2790)c1679 (60.2)769 (69.8)910 (53.9)<.001
I know that automation bias may influence the judgment based on GenAI outputs (n=2789)d1628 (58.4)743 (67.6)885 (52.4)<.001
I know that clinical expertise or skills may be lost with the long-term use of GenAI (n=2782)e1569 (56.4)664 (60.4)905 (53.8).001
I know that patients have the right to be informed about GenAI use (n=2777)f1356 (48.8)578 (52.5)778 (46.4).002
I think that history taking and physical examination remain crucial in the management of IDsg (n=2812)h2261 (80.4)965 (87.3)1296 (76)<.001
I think that understanding pathophysiology remains crucial in the management of IDs (n=2799)i2244 (80.2)958 (86.9)1286 (75.8)<.001
I think that clinical reasoning ability remains crucial in the management of IDs (n=2795)j2252 (80.6)951 (86.2)1301 (76.9)<.001
Affective domain
I consider the effectiveness of GenAI (n=2772)k1607 (58)764 (70)843 (50.2)<.001
I consider the safety of GenAI (n=2776)l1647 (59.3)755 (68.9)892 (53.1)<.001
I consider the fairness of GenAI for all patients (n=2770)m1311 (47.3)615 (56.3)696 (41.5)<.001
I consider the applicability of GenAI’s output to the specific clinical context (n=2765)n1584 (57.3)740 (67.8)844 (50.4)<.001
I consider the validity of GenAI’s output in terms of the clinical evidence (n=2768)o1663 (60.1)772 (70.7)891 (53.1)<.001
I consider transparency regarding GenAI use with patients (n=2774)p1381 (49.8)645 (58.9)736 (43.8)<.001

aResponses from some study participants are missing.

bOverall: n= 2799; GenAI users: n=1103; GenAI nonusers: n=1696.

cOverall: n= 2790; GenAI users: n=1101; GenAI nonusers: n=1689.

dOverall: n= 2789; GenAI users: n=1099; GenAI nonusers: n=1690.

eOverall: n= 2782; GenAI users: n=1099; GenAI nonusers: n=1683.

fOverall: n= 2777; GenAI users: n=1102; GenAI nonusers: n=1675.

gID: infectious disease.

hOverall: n= 2812; GenAI users: n=1106; GenAI nonusers: n=1706.

iOverall: n= 2799; GenAI users: n=1102; GenAI nonusers: n=1697.

jOverall: n= 2795; GenAI users: n=1103; GenAI nonusers: n=1692.

kOverall: n= 2772; GenAI users: n=1092; GenAI nonusers: n=1680.

lOverall: n= 2776; GenAI users: n=1095; GenAI nonusers: n=1681.

mOverall: n= 2770; GenAI users: n=1092; GenAI nonusers: n=1678.

nOverall: n= 2765; GenAI users: n=1091; GenAI nonusers: n=1674.

oOverall: n= 2768; GenAI users: n=1092; GenAI nonusers: n=1676.

pOverall: n= 2774; GenAI users: n=1095; GenAI nonusers: n=1679.

Similarly, users more often recognized essential competencies for ID management: history taking and physical examination (965/1106, 87.3% vs 1296/1706, 76%; P<.001), pathophysiological knowledge (958/1102, 86.9% vs 1286/1697, 75.8%; P<.001), and clinical reasoning (951/1103, 86.2% vs 1301/1692, 76.9%; P<.001).

Affective Domain of GenAI Use Among Resident Physicians

Overall, 57.3% (1584/2765) to 60.1% (1663/2768) of respondents assessed GenAI for effectiveness, safety, applicability, and validity, while 47.3% (1311/2770) and 49.8% (1381/2774) considered fairness and transparency, respectively. Across all domains, users showed greater ethical awareness than nonusers: effectiveness (764/1092, 70% vs 843/1680, 50.2%; P<.001), safety (755/1095, 68.9% vs 892/1681, 53.1%; P<.001), fairness (615/1092, 56.3% vs 696/1678, 41.5%, P<.001), applicability (740/1091, 67.8% vs 844/1674, 50.4%; P<.001), validity (772/1092, 70.7% vs 891/1676, 53.1%; P<.001), and transparency (645/1095, 58.9% vs 736/1679, 43.8%; P<.001).

Association Between GenAI Use and the Management of ID

GenAI use was independently associated with favorable behaviors (Table 3): thorough patient examination (adjusted odds ratio [aOR] 1.42, 95% CI 1.18‐1.70), appropriate antimicrobial selection (aOR 1.57, 95% CI 1.32‐1.87), familiarity with current epidemic information (aOR 1.46, 95% CI 1.22‐1.75), local antibiogram use (aOR 1.62, 95% CI 1.38‐1.89), individualized goal setting (aOR 1.64, 95% CI 1.40‐1.92), and individualized treatment strategy (aOR 1.45, 95% CI 1.23‐1.71).

Table 3. Association between the use of generative AI (GenAI) as a search engine and resident physicians’ and bedside behaviors regarding the management of infectious diseases (n=2850a).
VariablesGenAI users, n (%)GenAI nonusers, n (%)Adjusted odds ratio (95% CI)bP value
I examine patients thoroughly when suspecting infectious diseasesc861 (78.7)1221 (72.2)1.42 (1.18-1.70)<.001
I choose antimicrobials based on patient characteristics, suspected foci, and suspected organismsd821 (75.7)1122 (66.5)1.57 (1.32-1.87)<.001
I am familiar with information on the current epidemicse286 (26.3)334 (19.8)1.46 (1.22-1.75)<.001
I refer to the local antibiogram to choose antimicrobialsf563 (51.5)668 (39.6)1.62 (1.38-1.89)<.001
I set patient goals explicitly when the cure is deemed unattainableg550 (50.4)645 (38.4)1.64 (1.40-1.92)<.001
I consider the patient social background to determine the treatment strategyh743 (68.2)1009 (60.1)1.45 (1.23-1.71)<.001

aResponses from some study participants are missing.

bAdjusted odds ratios for GenAI use against GenAI nonuse were presented. Each estimate is an adjusted odds ratio in a multiple logistic regression model involving sex, postgraduate year, university or community hospital, infectious disease department rotation, the presence of antimicrobial stewardship programs, and overall General Medicine In-Training Examination score as covariates.

cOverall: n= 2785; GenAI users: n=1094; GenAI nonusers: n=1691.

dOverall: n= 2773; GenAI users: n=1085; GenAI nonusers: n=1688.

eOverall: n= 2772; GenAI users: n=1088; GenAI nonusers: n=1684.

fOverall: n= 2782; GenAI users: n=1094; GenAI nonusers: n=1688.

gOverall: n= 2772; GenAI users: n=1092; GenAI nonusers: n=1680.

hOverall: n= 2768; GenAI users: n=1089; GenAI nonusers: n=1679.

Sensitivity Analysis

A sensitivity analysis using an alternative cutoff for dichotomization of item responses was performed, which largely demonstrated consistency with the primary analysis regarding the trends of demographics, the 3 domains of GenAI, and the association between GenAI use and bedside behaviors. Statistically significant differences diminished in only 3 items: concerns over potential knowledge collapse and inadequate skill development, awareness of the necessity for transparency, and acknowledgment of the importance of clinical reasoning ability (Multimedia Appendices 1, 3 and 4).


Principal Findings

In this nationwide questionnaire survey of resident physicians in Japan conducted in January 2025, 39.4% (1124/2850) of respondents reported using GenAI as a search engine, although textbooks remained their primary educational resource. Perceived GenAI literacy and ethical considerations varied, with nonusers demonstrating lower familiarity. Fewer than half of respondents recognized the importance of disclosing GenAI use to patients. Notably, GenAI use was positively associated with preferred behaviors in the management of IDs.

Comparison to Prior Work

Despite its potential, the penetration of GenAI use as a search engine remained limited, both quantitatively and qualitatively, among resident physicians in Japan as of 2025. Consistent with earlier studies of physicians in training in the United States (2023) [24], Türkiye (2023‐2024) [25], and China (2024) [26], fewer than half of the respondents used GenAI in clinical practice. Furthermore, even among GenAI users, GenAI’s role as a search engine was peripheral, as most of them primarily used other tools. These findings may be at least partially explained by the unavailability of training for the appropriate application of GenAI [27]. Although GenAI offers opportunities for self-study, its output may be unsuitable for learners with differing levels of knowledge to interpret reliably [28]. Accordingly, structured education appears necessary to prepare resident physicians for the integration of GenAI into clinical practice.

Our study showed the systematic differences between GenAI users and nonusers. First, we found a lower likelihood of GenAI use among female resident physicians compared with their male counterparts. A study of physicians in training in the United States suggested a trend of less interest in GenAI among female than male respondents [24]. Probably, in the process of adopting new technology, female physicians prioritize social influence from their peers over its performance expectancy to determine whether to accept it [27]; they may defer their acceptance until GenAI is used by their peers. Second, nonusers consistently exhibited limited perceived GenAI literacy. According to the diffusion of innovations theory, the “early and late majority”—those likely to adopt GenAI in the future—tend to rely more on peer behavior (eg, colleagues’ GenAI use) than on theoretical understanding (eg, GenAI mechanisms), in contrast to “early adopters” (ie, current users) [29].

Our findings highlighted that transparency with patients was among the least considered aspects of GenAI use, although many respondents recognized the limitations of GenAI, such as confabulations and the possibility of biased outputs. The tendency of physicians to avoid disclosing GenAI use to patients has also been observed outside Japan [24] and may conflict with the principle that high-quality care should remain patient-centered [30]. From the patient’s perspective, ensuring transparency and explainability in the clinical decision-making process is critical [23], particularly as patients have begun voicing concerns about potential physician overreliance on GenAI [31,32].

In the present study, our hypothesis of knowledge collapse and inadequate skill development associated with GenAI use among resident physicians was not supported. Although this finding may be reassuring, the association may have been affected by several factors. First, unmeasured GenAI users’ traits, such as inquisitiveness, may have influenced the results. Second, other anticipated roles of GenAI, such as democratizing and accelerating access to context-specific medical knowledge, may have obscured the associations [33,34]. Nevertheless, empirical evidence regarding the long-term impact of GenAI on physicians’ performance remains limited, underscoring the need for further investigation.

Limitations

This study has several limitations. First, the cross-sectional design precludes assessment of causal relationships between GenAI use and physicians’ knowledge, attitudes, or behaviors. The associations among these factors may also have been affected by unmeasured variables, such as learners’ inquisitiveness and diligence, although we tried to mitigate their impact by including the GM-ITE score in our model. Longitudinal studies at multiple time points are required to capture changes and inform the timely development of medical education. Second, nonresponse bias may have influenced the findings, potentially leading to the overrepresentation of GenAI-familiar resident physicians. Although we suggested that GenAI literacy was insufficient among resident physicians, we may have underestimated the severity of the issue. Third, the validity and reliability of our original survey items have yet to be explored, although we conducted a pilot test to enhance face validity. Specifically, we measured perceived GenAI literacy via a survey as a surrogate for actual GenAI literacy, which requires direct observation in clinical settings. Given the possibility that some respondents who misunderstood GenAI literacy reported their awareness, our study findings may have overestimated the level of GenAI literacy among resident physicians. Finally, we analyzed most 5-point Likert scale items after dichotomizing them to improve interpretability. Therefore, we may have overlooked nuanced differences.

Future Directions

Our study findings underscore the need for residency programs to provide structured education on GenAI use in clinical contexts [6]. Such training should address not only effective prompt construction [35] but also the cultivation of critical appraisal skills to avoid premature closure [7,36] and the promotion of ethical considerations, including transparency with patients during patient care, all of which may need to be incorporated into future residency competency frameworks. The approach aligns with the recently proposed DEFT (diagnosis, evidence, feedback, and teaching)–AI framework for improving the quality of bedside GenAI education [7].

Conclusions

Resident physicians in Japan currently use GenAI as a search engine to a limited extent. Their literacy regarding GenAI remains inadequate, particularly among nonusers.

Acknowledgments

The authors would like to thank Editage [37] for English language editing. No generative AI tools were used to create this manuscript.

Funding

This work was supported in part by JSPS KAKENHI grant JP 23K16252 (awarded to KO).

Data Availability

The datasets generated or analyzed during this study are not publicly available due to privacy concerns but are available from the corresponding author on reasonable request.

Authors' Contributions

TM, KO, YN, and YT designed the study. YN and YT obtained the data. TM and KO analyzed the data. TM, KO, YN, and YT interpreted the data. TM drafted the manuscript. All authors critically reviewed the manuscript and approved the submitted version.

Conflicts of Interest

KO received honoraria for lectures from Kyorin Pharmaceutical Co, Thermo Fisher Scientific, Becton, Dickinson and Company, Eiken Chemical Co, and Terumo Co. YN received an honorarium from Japan Institute for Advancement of Medical Education Program (JAMEP) as a GM-ITE project manager. YT was the JAMEP director and received an honorarium from JAMEP as a speaker for the JAMEP lecture.

Multimedia Appendix 1

Association between the use of generative AI as a search engine and resident physicians’ demographics and educational resources using a different cutoff.

PDF File, 88 KB

Multimedia Appendix 2

Resident physicians’ perceived generative AI literacy in the cognitive and affective domains.

PDF File, 57 KB

Multimedia Appendix 3

Association between the use of generative AI (GenAI) as a search engine and resident physicians’ perceived GenAI literacy in cognitive and affective domains using a different cutoff (n=2850).

PDF File, 80 KB

Multimedia Appendix 4

Association between the use of generative AI as a search engine and resident physicians’ bedside behaviors regarding the management of infectious diseases using a different cutoff.

PDF File, 79 KB

  1. Haupt CE, Marks M. AI-generated medical advice-GPT and beyond. JAMA. Apr 25, 2023;329(16):1349-1350. [CrossRef] [Medline]
  2. Ong JC, Chang SY, William W, et al. Medical ethics of large language models in medicine. NEJM AI. Jun 17, 2024;1(7). [CrossRef]
  3. Ayers JW, Poliak A, Dredze M, et al. Comparing physician and artificial intelligence chatbot responses to patient questions posted to a public social media forum. JAMA Intern Med. Jun 1, 2023;183(6):589-596. [CrossRef] [Medline]
  4. Katz U, Cohen E, Shachar E, et al. GPT versus resident physicians — a benchmark based on official board scores. NEJM AI. Apr 12, 2024;1(5). [CrossRef]
  5. Howell MD, Corrado GS, DeSalvo KB. Three epochs of artificial intelligence in health care. JAMA. Jan 16, 2024;331(3):242-244. [CrossRef] [Medline]
  6. Schwartz IS, Link KE, Daneshjou R, Cortés-Penfield N. Black box warning: large language models and the future of infectious diseases consultation. Clin Infect Dis. Apr 10, 2024;78(4):860-866. [CrossRef] [Medline]
  7. Abdulnour RE, Gin B, Boscardin CK. Educational strategies for clinical supervision of artificial intelligence use. N Engl J Med. Aug 21, 2025;393(8):786-797. [CrossRef] [Medline]
  8. Furfaro D, Celi LA, Schwartzstein RM. Artificial intelligence in medical education: a long way to go. Chest. Apr 2024;165(4):771-774. [CrossRef] [Medline]
  9. Budzyń K, Romańczyk M, Kitala D, et al. Endoscopist deskilling risk after exposure to artificial intelligence in colonoscopy: a multicentre, observational study. Lancet Gastroenterol Hepatol. Oct 2025;10(10):896-903. [CrossRef] [Medline]
  10. Haug CJ, Drazen JM. Artificial intelligence and machine learning in clinical medicine, 2023. N Engl J Med. Mar 30, 2023;388(13):1201-1208. [CrossRef] [Medline]
  11. Loaiza-Bonilla A, Penberthy S. Harnessing Moravec’s paradox in health care: a new era of collaborative intelligence. NEJM AI. Apr 24, 2025;2(5). [CrossRef]
  12. Chang BS. Transformation of undergraduate medical education in 2023. JAMA. Oct 24, 2023;330(16):1521-1522. [CrossRef] [Medline]
  13. Nguyen T. ChatGPT in medical education: a precursor for automation bias? JMIR Med Educ. Jan 17, 2024;10:e50174. [CrossRef] [Medline]
  14. JAMEP. URL: https://jamep.or.jp [Accessed 2025-07-22]
  15. Miwa T, Okamoto K, Nishizaki Y, Tokuda Y. Infectious disease physician availability and postgraduate antimicrobial stewardship education in Japan. JAMA Netw Open. Mar 4, 2024;7(3):e244781. [CrossRef] [Medline]
  16. Miwa T, Okamoto K, Nishizaki Y, Tokuda Y. The characteristics of postgraduate antimicrobial stewardship education resources: a nationwide survey in Japan. J Hosp Infect. Dec 2024;154:137-139. [CrossRef] [Medline]
  17. Shikino K, Nishizaki Y, Kataoka K, et al. Association between physicians’ maldistribution and core clinical competency of resident physicians: a nationwide cross-sectional study. BMJ Open. Oct 18, 2024;14(10):e083184. [CrossRef] [Medline]
  18. Nishizaki Y, Nagasaki K, Shikino K, et al. Relationship between COVID-19 care and burnout among postgraduate clinical residents in Japan: a nationwide cross-sectional study. BMJ Open. Jan 13, 2023;13(1):e066348. [CrossRef] [Medline]
  19. Nagasaki K, Nishizaki Y, Shinozaki T, Kobayashi H, Tokuda Y. Association between resident duty hours and self-study time among postgraduate medical residents in Japan. JAMA Netw Open. Mar 1, 2021;4(3):e210782. [CrossRef] [Medline]
  20. Zaidi S, Nasir M. Teaching and Learning Methods in Medicine. Springer; 2014. ISBN: 9783319068497
  21. Armitage RC. ChatGPT: the threats to medical education. Postgrad Med J. Sep 21, 2023;99(1176):1130-1131. [CrossRef] [Medline]
  22. Sim I, Cassel C. The ethics of relational AI - expanding and implementing the Belmont principles. N Engl J Med. Jul 18, 2024;391(3):193-196. [CrossRef] [Medline]
  23. Jakobsen JC, Gluud C, Wetterslev J, Winkel P. When and how should multiple imputation be used for handling missing data in randomised clinical trials - a practical guide with flowcharts. BMC Med Res Methodol. Dec 6, 2017;17(1):162. [CrossRef] [Medline]
  24. Fried AJ, Dorn SD, Leland WJ, et al. Large language models in internal medicine residency: current use and attitudes among internal medicine residents. Discov Artif Intell. 2024;4:70. [CrossRef]
  25. Emekli E, Coşkun Ö, Budakoğlu I. The role of artificial intelligence in radiology residency training: a national survey study. Eur J Ther. 2024;30(6):844-849. [CrossRef]
  26. Zhou J, Zhang J, Wan R, et al. Integrating AI into clinical education: evaluating general practice trainees’ proficiency in distinguishing AI-generated hallucinations and impacting factors. BMC Med Educ. Mar 19, 2025;25(1):406. [CrossRef] [Medline]
  27. Scipion CE, Manchester MA, Federman A, Wang Y, Arias JJ. Barriers to and facilitators of clinician acceptance and use of artificial intelligence in healthcare settings: a scoping review. BMJ Open. Apr 15, 2025;15(4):e092624. [CrossRef] [Medline]
  28. Hu JM, Liu FC, Chu CM, Chang YT. Health care trainees’ and professionals’ perceptions of ChatGPT in improving medical knowledge training: rapid survey study. J Med Internet Res. Oct 18, 2023;25:e49385. [CrossRef] [Medline]
  29. Berwick DM. Disseminating innovations in health care. JAMA. Apr 16, 2003;289(15):1969-1975. [CrossRef] [Medline]
  30. Institute of Medicine (US) Committee on Quality of Health Care in America. Crossing the Quality Chasm: A New Health System for the 21st Century. National Academies Press (US); 2001. [Medline]
  31. Busch F, Hoffmann L, Xu L, et al. Multinational attitudes toward AI in health care and diagnostics among hospital patients. JAMA Netw Open. Jun 2, 2025;8(6):e2514452. [CrossRef] [Medline]
  32. Reis M, Reis F, Kunde W. Public perception of physicians who use artificial intelligence. JAMA Netw Open. Jul 1, 2025;8(7):e2521643. [CrossRef] [Medline]
  33. Lee P, Bubeck S, Petro J. Benefits, limits, and risks of GPT-4 as an AI chatbot for medicine. N Engl J Med. Mar 30, 2023;388(13):1233-1239. [CrossRef] [Medline]
  34. Succi MD, Chang BS, Rao AS. Building the AI-enabled medical school of the future. JAMA. May 20, 2025;333(19):1665-1666. [CrossRef] [Medline]
  35. Meskó B. Prompt engineering as an important emerging skill for medical professionals: tutorial. J Med Internet Res. Oct 4, 2023;25:e50638. [CrossRef] [Medline]
  36. Zwaan L. Cognitive bias in large language models: implications for research and practice. NEJM AI. Nov 27, 2024;1(12). [CrossRef]
  37. Editage. URL: https://www.editage.jp/ [Accessed 2026-07-10]


aOR: adjusted odds ratio
DEFT: diagnosis, evidence, feedback, and teaching
FAVES: fairness, appropriateness, validity, effectiveness, and safety
GenAI: generative AI
GM-ITE: General Medicine In-Training Examination
ID: infectious disease
JAMEP: Japan Institute for Advancement of Medical Education Program
PGY: postgraduate year
STROBE: Strengthening the Reporting of Observational Studies in Epidemiology


Edited by Andrew Coristine; submitted 17.Dec.2025; peer-reviewed by Hasan Durmus, Shinsuke Tanizaki, Weihua Yang; final revised version received 26.Jun.2026; accepted 27.Jun.2026; published 17.Jul.2026.

Copyright

© Toshiki Miwa, Koh Okamoto, Yuji Nishizaki, Yasuharu Tokuda. Originally published in JMIR AI (https://ai.jmir.org), 17.Jul.2026.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR AI, is properly cited. The complete bibliographic information, a link to the original publication on https://www.ai.jmir.org/, as well as this copyright and license information must be included.